Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
14 October 2015Website:
http://www.avalotx.comNext earnings report:
02 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 28 Jun 2024 21:13:59 GMTDividend
Analysts recommendations
Institutional Ownership
AVTX Latest News
WAYNE, Pa. and ROCKVILLE, Md., June 24, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Paul Varki has joined the Company as its Chief Legal Officer.
Avalo (AVTX) surges on adding a new pipeline drug, which has its origins at Eli Lilly. Alongside the acquisition, it also secured funding to continue operations beyond 2027.
Avalo Therapeutics (AVTX) stock price nosedived on Monday after the company published relatively weak financial results. It tumbled by over 23.5% in the pre-market session and reached a low of $16.60.
Avalo Therapeutics (NASDAQ: AVTX ) stock is rocketing higher on Thursday after announcing a couple of positive updates for investors in the clinical-stage biotechnology company. The first big update worth noting is the company securing $185 million through a private placement.
Avalo Therapeutics (AVTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GWRS, SRPT, AVTX, NTGR and PAY have been added to the Zacks Rank #1 (Strong Buy) List on January 3, 2024.
VVI, AVTX, RYI, TM and HIBB have been added to the Zacks Rank #1 (Strong Buy) List on November 27, 2023.
Are you looking for the best penny stocks to buy after the stock market dropped today? Believe it or not there are plenty of cheap stocks to watch that are heading higher amid this big drop in major indexes.
Avalo (AVTX) will receive an upfront payment of $150,000 on selling three compounds to AUG Therapeutics. The company is also eligible to receive milestone payments of up to $45 million.
Avalo Therapeutics (NASDAQ: AVTX ) stock is rising higher on Friday despite a lack of news from the biotechnology company. There haven't been any new press releases or filings from Avalo Therapeutics that explain why the stock is rising today.
What type of business is Avalo Therapeutics?
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the treatment of non-eosinophilic asthma, as well as inflammatory bowel disease, including moderate to severe Crohn's disease, and ulcerative colitis; and Phase III clinical trial for the treatment of COVID-19 acute respiratory distress syndrome. The company also engages in developing AVTX-007, a fully human Anti-IL-18 monoclonal antibody that is under Phase I clinical trial for the treatment of still's disease, including adult-onset still's disease and systemic juvenile idiopathic arthritis. Its products for rare genetic diseases in Phase III clinical trials include AVTX-801, a D-galactose substrate replacement therapy for the treatment of phosphoglucomutase 1 deficiency (PGM1), also known as PGM1-CDG; and AVTX-803, a L-fucose substrate replacement therapy for the treatment of LADII, also known as SLC35C1-CDG. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland.
What sector is Avalo Therapeutics in?
Avalo Therapeutics is in the Healthcare sector
What industry is Avalo Therapeutics in?
Avalo Therapeutics is in the Biotechnology industry
What country is Avalo Therapeutics from?
Avalo Therapeutics is headquartered in United States
When did Avalo Therapeutics go public?
Avalo Therapeutics initial public offering (IPO) was on 14 October 2015
What is Avalo Therapeutics website?
https://www.avalotx.com
Is Avalo Therapeutics in the S&P 500?
No, Avalo Therapeutics is not included in the S&P 500 index
Is Avalo Therapeutics in the NASDAQ 100?
No, Avalo Therapeutics is not included in the NASDAQ 100 index
Is Avalo Therapeutics in the Dow Jones?
No, Avalo Therapeutics is not included in the Dow Jones index
When does Avalo Therapeutics report earnings?
The next expected earnings date for Avalo Therapeutics is 02 August 2024